Mr. Gerstein is a Senior Advisor and Partner at BlueMountain. He is also a member of the Firm’s Valuation Committee and serves as a Director of several BlueMountain hedge funds. Since joining BlueMountain in 2004, Alan has held a number of key roles including CEO Europe and Senior Portfolio Manager overseeing Volatility and Fixed Income Arbitrage Strategies, and also managed the Risk Team. Prior to joining BlueMountain, Alan was a Vice President and Head of U.S. Investment Grade Credit Derivatives Trading at Goldman Sachs. Over a 10 year career at Goldman, Alan held several other senior positions including Head of U.S. Agency Bond Trading and in Interest Rate Derivatives Marketing. Prior to that, Alan was a Vice President of Interest Rate Derivatives Marketing at J.P. Morgan, where he worked with Andrew. Alan is a member of the MIT Corporation Development Committee and the Board of Trustees at Blythedale Children’s Hospital in Valhalla, NY. Alan holds an M.B.A. from the MIT Sloan School of Management and B.S. in Economics from the Massachusetts Institute of Technology.